[ad_1]
Decision on Eli Lilly’s Alzheimer’s drug delayed by U.S. FDA
The U.S. Food and Drug Administration has delayed its decision on Eli Lilly’s LLY.N experimental treatment for early Alzheimer’s disease.
[ad_2]
Source link
#Decision #Eli #Lillys #Alzheimers #drug #delayed #U.S #FDA